Your session is about to expire
← Back to Search
Other
Blood-Flow Restriction Exercise for Knee Replacement
N/A
Waitlist Available
Led By Steven Elmer
Research Sponsored by Michigan Technological University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
No previous history of knee injury/surgery (Arm 2)
40-75 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline at 10 weeks
Awards & highlights
Study Summary
This trial will study if using a B-FREE device to restrict blood flow during exercise is safe and effective in improving quadriceps muscle weakness following a TKR.
Who is the study for?
This trial is for adults aged 40-75 who have had a knee replacement over 6 months ago and haven't had previous knee injuries or surgeries. It's not for those with diabetes, heart conditions, neurological disorders, certain implanted devices, uncontrolled high blood pressure, or smokers.Check my eligibility
What is being tested?
The study tests the B-FREE method to see if it helps strengthen thigh muscles after total knee replacement surgery. Participants will use this exercise technique designed to improve muscle strength by restricting blood flow during exercise.See study design
What are the potential side effects?
While specific side effects are not listed, blood-flow restriction exercises may cause discomfort in the limb due to pressure from bands used to restrict blood flow and potential muscle soreness from exercising.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have never had a knee injury or surgery.
Select...
I am between 40 and 75 years old.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from baseline at 10 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline at 10 weeks
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Muscle size
Change in Muscle strength
Secondary outcome measures
Change in Balance
Change in Walking performance
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Adults with TKR Perform Home Exercise ProgramExperimental Treatment1 Intervention
Participants that have a total knee replacement will complete a home-based exercise program
Group II: Healthy Controls OnlyActive Control1 Intervention
Participants that have no history of knee joint dysfunction will serve as age-matched uninjured controls
Find a Location
Who is running the clinical trial?
Michigan Technological UniversityLead Sponsor
5 Previous Clinical Trials
667 Total Patients Enrolled
Blue Cross Blue Shield of Michigan FoundationOTHER
27 Previous Clinical Trials
51,170 Total Patients Enrolled
1 Trials studying Osteoarthritis
40 Patients Enrolled for Osteoarthritis
Steven ElmerPrincipal InvestigatorMichigan Technological University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You smoke cigarettes.I have had a heart attack or stroke.I have never had a knee injury or surgery.I have high blood pressure that is not controlled by medication.I had knee replacement surgery on one knee more than 6 months ago.I have diabetes.I have a heart or lung condition.I am between 40 and 75 years old.I have been diagnosed with a neurological disorder.
Research Study Groups:
This trial has the following groups:- Group 1: Healthy Controls Only
- Group 2: Adults with TKR Perform Home Exercise Program
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger